Phormed
Atlanta, US · 1 known investors
PhorMed is a clinical-stage biopharmaceutical company developing RLC/929, a targeted cell-repair immunotherapy that reduces inflammation to treat neurological diseases, cancer, and inflammatory lung disorders such as Acute Respiratory Distress Syndrome (ARDS). The company is advancing its pipeline through clinical trials in collaboration with clinical sites in Atlanta, Georgia.
Founders & leadership
BC
Ben ChangCEO
RM
Ralph MassaPresident of Sales, Marketing and Corporate Development
Investors · 1
Frequently asked questions
- What does Phormed do?
- PhorMed is a clinical-stage biopharmaceutical company developing RLC/929, a targeted cell-repair immunotherapy that reduces inflammation to treat neurological diseases, cancer, and inflammatory lung disorders such as Acute Respiratory Distress Syndrome (ARDS). The company is advancing its pipeline through clinical trials in collaboration with clinical sites in Atlanta, Georgia.
- Who are Phormed's investors?
- Phormed's investors include Edge Case Capital Partners.
- Where is Phormed headquartered?
- Phormed is headquartered in Atlanta, US.